Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in PH-HFpEF
NCT07288398Phase 3Active, not recruiting
- Sponsor
- Tenax Therapeutics
- Start
- Mar 2026
- Primary completion
- Jun 2028
- Countries
- 15
01
Overview
A Phase 3 trial of levosimendan in pulmonary hypertension (PH), sponsored by Tenax Therapeutics. Started Mar 2026; status: active, not recruiting.
02
Drugs
levosimendan
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT07288398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07288398.